注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Galmed Pharmaceuticals是一家以色列的臨床階段生物製藥公司。該公司的業務重點是開發治療肝臟疾病的療法。該公司的主要產品是Arachmol,這是一種肝臟靶向硬脂酰輔酶A去飽和酶1,用於口服治療NASH(非酒精性脂肪性肝炎)。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Vlad Ratziu | - | - | Member of Scientific Advisory Board |
Arun J. Sanyal | - | - | Member of Scientific Advisory Board |
Shmuel Nir | 59 | 2007 | Independent Director |
Amir Poshinski | 60 | 2020 | Independent Director |
David Sidransky | 61 | 2014 | Lead Independent Director |
Allen Baharaff | 56 | 2000 | Co-Founder, President, CEO & Chairman |
José María Mato de la Paz | - | - | Member of Scientific Advisory Board |
Shomron Ben-Horin | - | - | Member of Scientific Advisory Board |
Scott L. Friedman | - | - | Member of Scientific Advisory Board |
Carol L. Brosgart | 72 | 2017 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核